Journal Article
. 2011 Nov;197(6).
doi: 10.2214/AJR.10.4665.

3-T dynamic contrast-enhanced MRI of the breast: pharmacokinetic parameters versus conventional kinetic curve analysis

Riham H El Khouli 1 Katarzyna J Macura  Ihab R Kamel  Michael A Jacobs  David A Bluemke  
  • PMID: 22109308
  •     36 References
  •     33 citations


Objective: The purpose of this article is to evaluate the incremental value of pharmacokinetic analysis of dynamic contrast-enhanced (DCE) MRI compared with conventional breast MRI (morphology plus kinetic curve type analysis) in characterizing breast lesions as malignant or benign.

Subjects And Methods: Patients underwent 3D high-resolution T1-weighted contrast-enhanced MRI and DCE-MRI at 3 T and had pathology-proven diagnosis (95%) or more than 2 years of follow-up confirming lesion stability (5%). Lesions were identified using the high-spatial-resolution contrast-enhanced MRI. Morphologic features (margin, enhancement, and pattern) and conventional DCE-MRI results (kinetic curve types 1, 2, or 3) or pharmacokinetic parameters (forward volume transfer constant [K(trans)], reverse volume transfer constant [K(ep)], and the extravascular extracellular space volume per unit volume of tissue), were included in multivariate models for prediction of benign versus malignant diagnosis.

Results: Ninety-five patients with 101 lesions were included: 52% of patients were premenopausal and 48% were postmenopausal. Sixty-eight lesions (67.3%) were malignant and 33 (32.7%) were benign. There was a significant association between K(trans) and K(ep) and the diagnosis of benign versus malignant (p < 0.001). The area under the curve for morphologic features (lesion margin and enhancement pattern) was 0.85, whereas inclusion of K(trans) or K(ep) in the model showed similar modest improvement in performance (area under the curve, 0.88-0.89). For DCE-MRI, both pharmacokinetic modeling and kinetic curve type analysis improved characterization of malignant and benign breast lesions. A diagnostic model including lesion morphology plus either pharmacokinetic parameters or kinetic curve assessment showed similar diagnostic performance in characterizing breast lesions.

Conclusion: The use of kinetic curve type assessment or pharmacokinetic modeling in conjunction with high-resolution 3D breast MRI appears to offer similar improvement in diagnostic performance. Although morphologic analysis alone provides good characterization of breast lesions on MRI as benign or malignant, analysis of the lesion perfusion on DCE-MRI using either kinetic curve shape assessment or a pharmacokinetic modeling approach improves diagnostic accuracy.

Tumor angiogenesis, vascularization, and contrast-enhanced magnetic resonance imaging.
Z M Bhujwalla, D Artemov, J Glockner.
Top Magn Reson Imaging, 1999 Nov 07; 10(2). PMID: 10551624
Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability.
K Kinkel, T H Helbich, +4 authors, N M Hylton.
AJR Am J Roentgenol, 2000 Jul 06; 175(1). PMID: 10882243
Dynamic image interpretation of MRI of the breast.
C K Kuhl, H H Schild.
J Magn Reson Imaging, 2000 Dec 06; 12(6). PMID: 11105038
Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies.
D M Ikeda, N M Hylton, +9 authors, M D Schnall.
J Magn Reson Imaging, 2001 May 31; 13(6). PMID: 11382949
A combined architectural and kinetic interpretation model for breast MR images.
M D Schnall, S Rosten, +2 authors, L W Nunes.
Acad Radiol, 2001 Jul 14; 8(7). PMID: 11450959
Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting glioma.
A Jackson, G C Jayson, +4 authors, J C Waterton.
Br J Radiol, 2003 Apr 10; 76(903). PMID: 12684231
Dynamic MR imaging of the breast. Analysis of kinetic and morphologic diagnostic criteria.
B K Szabó, P Aspelin, M Kristoffersen Wiberg, B Boné.
Acta Radiol, 2003 Jul 09; 44(4). PMID: 12846687
Detection of breast malignancy: diagnostic MR protocol for improved specificity.
Wei Huang, Paul R Fisher, +3 authors, Terry M Button.
Radiology, 2004 Jun 19; 232(2). PMID: 15205478
Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers.
H J Weinmann, M Laniado, W Mützel.
Physiol Chem Phys Med NMR, 1984 Jan 01; 16(2). PMID: 6505043
Highly Cited.
Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging.
G Brix, W Semmler, +3 authors, W J Lorenz.
J Comput Assist Tomogr, 1991 Jul 01; 15(4). PMID: 2061479
Highly Cited.
Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast enhanced MRI.
F W Flickinger, J D Allison, R M Sherry, J C Wright.
Magn Reson Imaging, 1993 Jan 01; 11(5). PMID: 8345775
Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model.
P S Tofts, B Berkowitz, M D Schnall.
Magn Reson Med, 1995 Apr 01; 33(4). PMID: 7776889
The intravascular contribution to fMRI signal change: Monte Carlo modeling and diffusion-weighted studies in vivo.
J L Boxerman, P A Bandettini, +4 authors, R M Weisskoff.
Magn Reson Med, 1995 Jul 01; 34(1). PMID: 7674897
Highly Cited.
Modeling tracer kinetics in dynamic Gd-DTPA MR imaging.
P S Tofts.
J Magn Reson Imaging, 1997 Jan 01; 7(1). PMID: 9039598
Highly Cited. Review.
Dynamic MRI of invasive breast cancer: assessment of three region-of-interest analysis methods.
S Mussurakis, D L Buckley, A Horsman.
J Comput Assist Tomogr, 1997 May 01; 21(3). PMID: 9135653
Microvessel density of invasive breast cancer assessed by dynamic Gd-DTPA enhanced MRI.
D L Buckley, P J Drew, +2 authors, A Horsman.
J Magn Reson Imaging, 1997 May 01; 7(3). PMID: 9170027
Mapping pathophysiological features of breast tumors by MRI at high spatial resolution.
H Degani, V Gusis, +2 authors, S Strano.
Nat Med, 1997 Jul 01; 3(7). PMID: 9212107
Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?
C K Kuhl, P Mielcareck, +4 authors, H H Schild.
Radiology, 1999 Apr 06; 211(1). PMID: 10189459
Highly Cited.
Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.
P S Tofts, G Brix, +10 authors, R M Weisskoff.
J Magn Reson Imaging, 1999 Oct 03; 10(3). PMID: 10508281
Highly Cited. Review.
Model selection and model averaging in phylogenetics: advantages of akaike information criterion and bayesian approaches over likelihood ratio tests.
David Posada, Thomas R Buckley.
Syst Biol, 2004 Nov 17; 53(5). PMID: 15545256
Highly Cited.
Magnetic resonance imaging of the breast prior to biopsy.
David A Bluemke, Constantine A Gatsonis, +14 authors, Mitchell D Schnall.
JAMA, 2004 Dec 09; 292(22). PMID: 15585733
Highly Cited.
Evidence for shutter-speed variation in CR bolus-tracking studies of human pathology.
Thomas E Yankeelov, William D Rooney, +6 authors, Charles S Springer.
NMR Biomed, 2004 Dec 04; 18(3). PMID: 15578708
Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model.
Thomas E Yankeelov, Jeffrey J Luci, +5 authors, John C Gore.
Magn Reson Imaging, 2005 May 28; 23(4). PMID: 15919597
Color-coded automated signal intensity curves for detection and characterization of breast lesions: preliminary evaluation of a new software package for integrated magnetic resonance-based breast imaging.
Federica Pediconi, Carlo Catalano, +8 authors, Roberto Passariello.
Invest Radiol, 2005 Jun 24; 40(7). PMID: 15973137
Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.
Christiane K Kuhl, Hans H Schild, Nuschin Morakkabati.
Radiology, 2005 Aug 25; 236(3). PMID: 16118161
Diagnostic architectural and dynamic features at breast MR imaging: multicenter study.
Mitchell D Schnall, Jeffrey Blume, +14 authors, Constantine A Gatsonis.
Radiology, 2005 Dec 24; 238(1). PMID: 16373758
Highly Cited.
Differentiation of benign from malignant breast disease associated with screening detected microcalcifications using dynamic contrast enhanced magnetic resonance imaging.
P J Kneeshaw, M Lowry, +3 authors, L W Turnbull.
Breast, 2005 Jul 09; 15(1). PMID: 16002292
Evaluation of quantitative parametric analysis for characterization of breast lesions in contrast-enhanced MR mammography.
E A M Hauth, H Jaeger, +4 authors, M Forsting.
Eur Radiol, 2006 Aug 10; 16(12). PMID: 16896702
Breast MR imaging: computer-aided evaluation program for discriminating benign from malignant lesions.
Teresa C Williams, Wendy B DeMartini, +2 authors, Constance D Lehman.
Radiology, 2007 May 18; 244(1). PMID: 17507720
Measurement of pharmacokinetic parameters in histologically graded invasive breast tumours using dynamic contrast-enhanced MRI.
A Radjenovic, B J Dall, J P Ridgway, M A Smith.
Br J Radiol, 2007 Dec 12; 81(962). PMID: 18070824
Quantitative 2- and 3-dimensional analysis of pharmacokinetic model-derived variables for breast lesions in dynamic, contrast-enhanced MR mammography.
E A M Hauth, H J Jaeger, +3 authors, M Forsting.
Eur J Radiol, 2007 Jul 31; 66(2). PMID: 17658235
[Quantitative parametric analysis of contrast-enhanced lesions in dynamic MR mammography].
E A M Hauth, H Jaeger, +3 authors, M Forsting.
Radiologe, 2007 Nov 16; 48(6). PMID: 18004537
Magnetic resonance imaging of the breast.
Riham H El Khouli, Michael A Jacobs, David A Bluemke.
Semin Roentgenol, 2008 Sep 09; 43(4). PMID: 18774031
Dynamic contrast-enhanced (DCE) derived transfer coefficient (ktrans) is a surrogate marker of matrix metalloproteinase 9 (MMP-9) expression in brain tuberculomas.
Mohammad Haris, Nuzhat Husain, +4 authors, Rakesh K Gupta.
J Magn Reson Imaging, 2008 Sep 09; 28(3). PMID: 18777539
The magnetic resonance shutter speed discriminates vascular properties of malignant and benign breast tumors in vivo.
Wei Huang, Xin Li, +7 authors, Charles S Springer.
Proc Natl Acad Sci U S A, 2008 Nov 14; 105(46). PMID: 19004780    Free PMC article.
Dynamic contrast-enhanced MRI of the breast: quantitative method for kinetic curve type assessment.
Riham H El Khouli, Katarzyna J Macura, +4 authors, David A Bluemke.
AJR Am J Roentgenol, 2009 Sep 23; 193(4). PMID: 19770298    Free PMC article.
Comparative analysis of nonlinear dimensionality reduction techniques for breast MRI segmentation.
Alireza Akhbardeh, Michael A Jacobs.
Med Phys, 2012 Apr 10; 39(4). PMID: 22482648    Free PMC article.
Strain-encoded breast MRI in phantom and ex vivo specimens with histological validation: preliminary results.
Ahmed A Haruoni, Jakir Hossain, +4 authors, Michael A Jacobs.
Med Phys, 2012 Dec 13; 39(12). PMID: 23231318    Free PMC article.
A review of breast tomosynthesis. Part II. Image reconstruction, processing and analysis, and advanced applications.
Ioannis Sechopoulos.
Med Phys, 2013 Jan 10; 40(1). PMID: 23298127    Free PMC article.
Is there any correlation between model-based perfusion parameters and model-free parameters of time-signal intensity curve on dynamic contrast enhanced MRI in breast cancer patients?
Boram Yi, Doo Kyoung Kang, +4 authors, Tae Hee Kim.
Eur Radiol, 2014 Feb 21; 24(5). PMID: 24553785
The effects of applying breast compression in dynamic contrast material-enhanced MR imaging.
Riham H El Khouli, Katarzyna J Macura, +2 authors, Michael A Jacobs.
Radiology, 2014 Mar 14; 272(1). PMID: 24620911    Free PMC article.
Progesterone-targeted magnetic resonance imaging probes.
Taryn R Townsend, Georgette Moyle-Heyrman, +3 authors, Thomas J Meade.
Bioconjug Chem, 2014 Jul 16; 25(8). PMID: 25019183    Free PMC article.
Influence of scan duration on the estimation of pharmacokinetic parameters for breast lesions: a study based on CAIPIRINHA-Dixon-TWIST-VIBE technique.
Wen Hao, Bin Zhao, +2 authors, Hui Liu.
Eur Radiol, 2014 Oct 18; 25(4). PMID: 25323603
Diagnosis of brain tumors using dynamic contrast-enhanced perfusion imaging with a short acquisition time.
Takashi Abe, Yoshifumi Mizobuchi, +8 authors, Masafumi Harada.
Springerplus, 2015 Mar 21; 4. PMID: 25793147    Free PMC article.
Quantitative discrimination between invasive ductal carcinomas and benign lesions based on semi-automatic analysis of time intensity curves from breast dynamic contrast enhanced MRI.
Jiandong Yin, Jiawen Yang, +2 authors, Wei Zhang.
J Exp Clin Cancer Res, 2015 Apr 19; 34. PMID: 25887917    Free PMC article.
Informational analysis: a Shannon theoretic approach to measure the performance of a diagnostic test.
Rossano Girometti, Francesco Fabris.
Med Biol Eng Comput, 2015 Apr 22; 53(9). PMID: 25894466
Multiparametric and Multimodality Functional Radiological Imaging for Breast Cancer Diagnosis and Early Treatment Response Assessment.
Michael A Jacobs, Antonio C Wolff, +5 authors, Richard Wahl.
J Natl Cancer Inst Monogr, 2015 Jun 13; 2015(51). PMID: 26063885    Free PMC article.
Combined reading of Contrast Enhanced and Diffusion Weighted Magnetic Resonance Imaging by using a simple sum score.
Anja Baltzer, Matthias Dietzel, Clemens G Kaiser, Pascal A Baltzer.
Eur Radiol, 2015 Jun 28; 26(3). PMID: 26115653
Relating Doses of Contrast Agent Administered to TIC and Semi-Quantitative Parameters on DCE-MRI: Based on a Murine Breast Tumor Model.
Menglin Wu, Li Lu, +4 authors, Xuening Zhang.
PLoS One, 2016 Feb 24; 11(2). PMID: 26901876    Free PMC article.
Ultrafast Bilateral DCE-MRI of the Breast with Conventional Fourier Sampling: Preliminary Evaluation of Semi-quantitative Analysis.
Federico D Pineda, Milica Medved, +7 authors, Gregory S Karczmar.
Acad Radiol, 2016 Jun 11; 23(9). PMID: 27283068    Free PMC article.
DCE-MRI-Derived Parameters in Evaluating Abraxane-Induced Early Vascular Response and the Effectiveness of Its Synergistic Interaction with Cisplatin.
Xilin Sun, Lili Yang, +6 authors, Baozhong Shen.
PLoS One, 2016 Sep 16; 11(9). PMID: 27632532    Free PMC article.
Characteristics of quantitative perfusion parameters on dynamic contrast-enhanced MRI in mammographically occult breast cancer.
Jung Kyu Ryu, Sun Jung Rhee, +2 authors, Geon-Ho Jahng.
J Appl Clin Med Phys, 2016 Sep 30; 17(5). PMID: 27685105    Free PMC article.
The potential of multiparametric MRI of the breast.
Katja Pinker, Thomas H Helbich, Elizabeth A Morris.
Br J Radiol, 2016 Nov 03; 90(1069). PMID: 27805423    Free PMC article.
Evaluation of optimized magnetic resonance perfusion imaging scanning time window after contrast agent injection for differentiating benign and malignant breast lesions.
Jie Dong, Dawei Wang, +3 authors, Jiandong Zhang.
Exp Ther Med, 2017 Apr 30; 13(3). PMID: 28450944    Free PMC article.
Dynamic Contrast-enhanced MRI in Renal Tumors: Common Subtype Differentiation using Pharmacokinetics.
Hai-Yi Wang, Zi-Hua Su, +9 authors, Hui-Yi Ye.
Sci Rep, 2017 Jun 10; 7(1). PMID: 28596583    Free PMC article.
Discrimination between benign and malignant breast lesions using volumetric quantitative dynamic contrast-enhanced MR imaging.
Ziliang Cheng, Zhuo Wu, +6 authors, Jun Shen.
Eur Radiol, 2017 Sep 21; 28(3). PMID: 28929243
Background, current role, and potential applications of radiogenomics.
Katja Pinker, Fuki Shitano, +6 authors, Elizabeth A Morris.
J Magn Reson Imaging, 2017 Nov 03; 47(3). PMID: 29095543    Free PMC article.
Highly Cited. Review.
Contrast-enhanced dynamic and diffusion-weighted magnetic resonance imaging at 3.0 T to assess early-stage nasopharyngeal carcinoma.
Liangping Ni, Ying Liu.
Oncol Lett, 2018 Mar 20; 15(4). PMID: 29552169    Free PMC article.
Early Contrast Enhancement: A novel magnetic resonance imaging biomarker of pleural malignancy.
Selina Tsim, Catherine A Humphreys, +8 authors, Kevin G Blyth.
Lung Cancer, 2018 Mar 25; 118. PMID: 29572002    Free PMC article.
Discrimination between malignant and benign mass-like lesions from breast dynamic contrast enhanced MRI: semi-automatic vs. manual analysis of the signal time-intensity curves.
Jiandong Yin, Jiawen Yang, Zejun Jiang.
J Cancer, 2018 Mar 28; 9(5). PMID: 29581761    Free PMC article.
Accuracy and precision of quantitative DCE-MRI parameters: How should one estimate contrast concentration?
Nicole Wake, Hersh Chandarana, +4 authors, Sungheon Gene Kim.
Magn Reson Imaging, 2018 May 20; 52. PMID: 29777820    Free PMC article.
Feasibility study of dual parametric 2D histogram analysis of breast lesions with dynamic contrast-enhanced and diffusion-weighted MRI.
Yanqiong Chen, Bin Wu, +2 authors, Yajia Gu.
J Transl Med, 2018 Nov 25; 16(1). PMID: 30470241    Free PMC article.
Diagnostic performance of initial enhancement analysis using ultra-fast dynamic contrast-enhanced MRI for breast lesions.
Mariko Goto, Koji Sakai, +6 authors, Kei Yamada.
Eur Radiol, 2018 Aug 09; 29(3). PMID: 30088064
Magnetic resonance imaging semantic and quantitative features analyses: an additional diagnostic tool for breast phyllodes tumors.
Wenjuan Ma, Xinpeng Guo, +8 authors, Chao Zhang.
Am J Transl Res, 2020 Jun 09; 12(5). PMID: 32509202    Free PMC article.
Use of MRI for Personalized Treatment of More Aggressive Tumors.
Riham H El Khouli, Michael A Jacobs.
Radiology, 2020 Apr 03; 295(3). PMID: 32233918    Free PMC article.
Classification of breast mass lesions on dynamic contrast-enhanced magnetic resonance imaging by a computer-assisted diagnosis system based on quantitative analysis.
Jiandong Yin, Jiawen Yang, Zejun Jiang.
Oncol Lett, 2019 Mar 15; 17(3). PMID: 30867727    Free PMC article.
Integrated Multiparametric Radiomics and Informatics System for Characterizing Breast Tumor Characteristics with the OncotypeDX Gene Assay.
Michael A Jacobs, Christopher B Umbricht, +5 authors, Antonio C Wolff.
Cancers (Basel), 2020 Oct 01; 12(10). PMID: 32992569    Free PMC article.
Impact of the Number of Iterations in Compressed Sensing Reconstruction on Ultrafast Dynamic Contrast-enhanced Breast MR Imaging.
Hajime Sagawa, Masako Kataoka, +4 authors, Kaori Togashi.
Magn Reson Med Sci, 2018 Nov 13; 18(3). PMID: 30416179    Free PMC article.
Pharmacokinetic Analysis of Dynamic Contrast-Enhanced Magnetic Resonance Imaging at 7T for Breast Cancer Diagnosis and Characterization.
R Elena Ochoa-Albiztegui, Varadan Sevilimedu, +6 authors, Katja Pinker.
Cancers (Basel), 2020 Dec 18; 12(12). PMID: 33327532    Free PMC article.